Ventilator News and Research RSS Feed - Ventilator News and Research

Hospitals see sharp declines in rates of CLABSIs and ventilator-associated pneumonias

Hospitals see sharp declines in rates of CLABSIs and ventilator-associated pneumonias

Hospitals across the country have seen sharp declines in rates of central line-associated blood stream infections (CLABSIs) and ventilator-associated pneumonias (VAPs) among critically ill neonates and children, according to a new study in the journal Pediatrics. [More]
State highlights: Mass. health spending slows, but for how long?

State highlights: Mass. health spending slows, but for how long?

Two years ago, Massachusetts set what was considered an ambitious goal: The state would not let that persistent monster, rising health care costs, increase faster than the economy as a whole. [More]
Trends and developments of the global ventilators market

Trends and developments of the global ventilators market

Ventilators Market To 2020 - Technical Advances And Hospital Expansion Serve As Distinct Regional Growth Drivers [More]
Cancer fighter may also help patients survive pneumonia

Cancer fighter may also help patients survive pneumonia

The tip of an immune molecule known for its skill at fighting cancer may also help patients survive pneumonia, scientists report. [More]
Research report on global market for respiratory devices

Research report on global market for respiratory devices

The worldwide respiratory device market continues to grow despite economic downturns mainly due to the aging of the world population and increasing incidence of COPD. [More]
Expert guidance helps prioritize strategies to prevent VAP

Expert guidance helps prioritize strategies to prevent VAP

Thousands of critically ill patients on life support develop ventilator-associated pneumonia (VAP) each year. A new document released today by a consortium of professional organizations helps prioritize strategies to prevent this potentially fatal infection. [More]
Novel oxygen uptake parameter aids idiopathic PAH evaluation

Novel oxygen uptake parameter aids idiopathic PAH evaluation

Oxygen uptake efficiency plateau, measured during the cardiopulmonary exercise test, offers a novel method for evaluating gas exchange abnormalities in patients with idiopathic pulmonary hypertension, Chinese researchers report. [More]
AACN conference addresses educational, professional development goals for progressive care nurses

AACN conference addresses educational, professional development goals for progressive care nurses

AACN Progressive Care Pathways, presented by the American Association of Critical-Care Nurses, is the only conference to address the distinct educational and professional development goals for the growing number of nurses who care for high acuity patients who are not in the ICU but require highly skilled nursing care. [More]
Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Cubist Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration approved SIVEXTRO (tedizolid phosphate) for the treatment of adult acute bacterial skin and skin structure infections (ABSSSI). [More]
Longer looks: Caregivers effort to stay well; patients who turn to religion for cures; new views on postpartum depression

Longer looks: Caregivers effort to stay well; patients who turn to religion for cures; new views on postpartum depression

More than 65 million people, or 29 percent of the U.S. population, provide care for a chronically ill, disabled or aged family members or friends during any given year, and spend an average of 20 hours per week providing that care. [More]
UCF College of Nursing interim dean receives NIH grant to improve care for critically-ill patients

UCF College of Nursing interim dean receives NIH grant to improve care for critically-ill patients

More than one hospital television drama has played out an emergency room scene where a patient has to be "tubed" to re-establish breathing. [More]
Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals publishes positive results from Phase 3 clinical trial of SIVEXTRO

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that The Lancet Infectious Diseases published online the positive results from ESTABLISH-2, a pivotal Phase 3 clinical trial of the investigational antibiotic SIVEXTRO™ (tedizolid phosphate), which is being developed for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and complicated skin and soft tissue infections (cSSTI). [More]
First Edition: June 3, 2014

First Edition: June 3, 2014

Today's headlines include coverage of Medicare data released Monday indicating that 2012 charges for some common inpatient hospital procedures dramatically increased over the previous year. [More]
Patients with chronic pulmonary thromboembolic disease may benefit from PTE

Patients with chronic pulmonary thromboembolic disease may benefit from PTE

Patients with chronic pulmonary thromboembolic disease may benefit from pulmonary thromboendarterectomy (PTE), even if the patients don't have severe pulmonary hypertension, according to University of California, San Diego, researchers. [More]

iMDsoft provides tele-health solutions that ensure best possible remote care

iMDsoft is committed to providing tele-health solutions that ensure the best possible remote care. The company's tele-ICU solution, MVcentralTM, enables intensivists to provide care around the clock from a remote command center and communicate with the hospital-based clinical team. [More]
Covidien net sales increase 3% to $2.60 billion in second quarter fiscal 2014

Covidien net sales increase 3% to $2.60 billion in second quarter fiscal 2014

Covidien plc today announced financial results for the second quarter of fiscal 2014. Second-quarter net sales of $2.60 billion increased 3% from the $2.53 billion in the second quarter a year ago. Operational sales growth was 4% in the second quarter, as foreign exchange rate movement lowered the quarterly sales growth rate by just over one percentage point. [More]
Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI). [More]
FDA grants clearance for Breathe Technologies’ Non-Invasive Open Ventilation System

FDA grants clearance for Breathe Technologies’ Non-Invasive Open Ventilation System

Breathe Technologies, Inc. announced today that the U.S. Food and Drug Administration has granted the fifth 510(k) clearance for its Non-Invasive Open Ventilation System, allowing its use with compressed air supply for non-oxygen dependent patients. [More]
Expert guidance highlights strategies to prevent catheter-associated urinary tract infections

Expert guidance highlights strategies to prevent catheter-associated urinary tract infections

New expert guidance highlights strategies for implementing and prioritizing efforts to prevent catheter-associated urinary tract infections (CAUTI) in hospitals. [More]
Study: A record number of elderly people are completing living wills to guide end-of-life medical treatments

Study: A record number of elderly people are completing living wills to guide end-of-life medical treatments

A record number of elderly people are completing living wills to guide end-of-life medical treatments - up from 47 percent in 2000 to 72 percent in 2010 - according to new research from the University of Michigan and the Veterans Affairs Ann Arbor Healthcare System. [More]